HPV Testing and Pap Test Market: By Product Type (HPV test, Pap test and Co-test); By Application (Cervical cancer and Vaginal cancer); By Distribution Channel (Hospitals and clinics, Diagnostic centers and Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
HPV Testing and Pap Test Market: By Product Type (HPV test, Pap test and Co-test); By Application (Cervical cancer and Vaginal cancer); By Distribution Channel (Hospitals and clinics, Diagnostic centers and Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts T%li%2032
PRODUCT OVERVIEW
The most prevalent sexually transmitted infection in the world is caused by the papillomaviridae family's Human Papillomavirus (HPV). HPV is divided int%li%tw%li%categories, such as low-risk HPVs and high-risk HPVs, depending on the risk involved. Cervical and vaginal cancers are now well known t%li%be caused by high-risk strains of the HPV virus. A double-stranded DNA tumour virus called the human papillomavirus promotes the growth of epithelial cells on the cutaneous and mucosal surfaces.
MARKET HIGHLIGHTS
The HPV Testing and Pap Test Market is expected t%li%project a notable CAGR of 7.4% in 2032.
HPV Testing and Pap Test Market is expected t%li%surpass USD 9.10 billion by 2032 from USD 2.99 billion in 2021 at a CAGR of 7.4% in the coming years, i.e., 2022-32. Rising demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers is one of the main factors anticipated t%li%propel the market for human papillomavirus testing and Pap tests over the forecast period. The market for Pap tests and human papillomavirus testing is anticipated t%li%be driven by a number of technological developments, such as the creation of human papillomavirus type 16 and the use of various molecular markers in screening techniques.
HPV TESTING AND PAP TEST MARKET: SEGMENTS
The pap test segment is expected t%li%grow with a higher CAGR during 2022-32
HPV Testing and Pap Test Market is categorized on the basis of Product Type int%li%HPV test, Pap test and Co-test. Due t%li%its extensive adoption in screening programs, the Pap test segment led the market for HPV testing and Pap tests in 2021. Further measures t%li%raise public knowledge about Pap tests are anticipated t%li%fuel the segment's expansion. Initial screening using HPV tests aids in finding abnormal cells that could develop int%li%cancer. This aids in the early detection of disease and enables medical professionals t%li%choose from a variety of preventive and/or therapeutic measures. As a result, it is projected that the HPV testing market would expand over the forecast period.
The hospital segment is expected t%li%grow with a higher CAGR during 2022-32
HPV Testing and Pap Test Market is categorized on the basis of distribution channel int%li%Hospitals and clinics, Diagnostic centers and Others. With an increase in patient load, pap test and HPV testing procedures will become more common in hospitals. Healthcare spending is rising as a result of an increased availability of cutting-edge equipment, the presence of skilled personnel, and a booming demand for relatively inexpensive diagnostic procedures. The availability of well-equipped assays and test kits for the detection of cervical and vaginal cancer in both public and private institutions, as well as the influx of numerous sophisticated technologies, will encourage the market's expansion.
Get More Information - Download Free Sample
MARKET DYNAMICS
Growth Drivers
Development of new screening test kits and increasing cases of cervical cancer
Need for technological improvements and awareness campaigns is expected t%li%surge demand
Restraint
Modifications t%li%regulatory standards and high pricing is likely t%li%hamper the Market Growth
HPV TESTING AND PAP TEST MARKET:
Key Players
HPV Testing and Pap Test Market Segments:
PRODUCT OVERVIEW
The most prevalent sexually transmitted infection in the world is caused by the papillomaviridae family's Human Papillomavirus (HPV). HPV is divided int%li%tw%li%categories, such as low-risk HPVs and high-risk HPVs, depending on the risk involved. Cervical and vaginal cancers are now well known t%li%be caused by high-risk strains of the HPV virus. A double-stranded DNA tumour virus called the human papillomavirus promotes the growth of epithelial cells on the cutaneous and mucosal surfaces.
MARKET HIGHLIGHTS
The HPV Testing and Pap Test Market is expected t%li%project a notable CAGR of 7.4% in 2032.
HPV Testing and Pap Test Market is expected t%li%surpass USD 9.10 billion by 2032 from USD 2.99 billion in 2021 at a CAGR of 7.4% in the coming years, i.e., 2022-32. Rising demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers is one of the main factors anticipated t%li%propel the market for human papillomavirus testing and Pap tests over the forecast period. The market for Pap tests and human papillomavirus testing is anticipated t%li%be driven by a number of technological developments, such as the creation of human papillomavirus type 16 and the use of various molecular markers in screening techniques.
HPV TESTING AND PAP TEST MARKET: SEGMENTS
The pap test segment is expected t%li%grow with a higher CAGR during 2022-32
HPV Testing and Pap Test Market is categorized on the basis of Product Type int%li%HPV test, Pap test and Co-test. Due t%li%its extensive adoption in screening programs, the Pap test segment led the market for HPV testing and Pap tests in 2021. Further measures t%li%raise public knowledge about Pap tests are anticipated t%li%fuel the segment's expansion. Initial screening using HPV tests aids in finding abnormal cells that could develop int%li%cancer. This aids in the early detection of disease and enables medical professionals t%li%choose from a variety of preventive and/or therapeutic measures. As a result, it is projected that the HPV testing market would expand over the forecast period.
The hospital segment is expected t%li%grow with a higher CAGR during 2022-32
HPV Testing and Pap Test Market is categorized on the basis of distribution channel int%li%Hospitals and clinics, Diagnostic centers and Others. With an increase in patient load, pap test and HPV testing procedures will become more common in hospitals. Healthcare spending is rising as a result of an increased availability of cutting-edge equipment, the presence of skilled personnel, and a booming demand for relatively inexpensive diagnostic procedures. The availability of well-equipped assays and test kits for the detection of cervical and vaginal cancer in both public and private institutions, as well as the influx of numerous sophisticated technologies, will encourage the market's expansion.
Get More Information - Download Free Sample
MARKET DYNAMICS
Growth Drivers
Development of new screening test kits and increasing cases of cervical cancer
Need for technological improvements and awareness campaigns is expected t%li%surge demand
Restraint
Modifications t%li%regulatory standards and high pricing is likely t%li%hamper the Market Growth
HPV TESTING AND PAP TEST MARKET:
Key Players
- Arbor vita corporation
- Becton, Dickinson & Company
- Qiagen NV
- Diagcor Bioscience Incorporation Ltd.
- Enz%li%Biochem, Inc.
- F. Hoffmann-La Roche AG
- Hologic, Inc.
- Mylab Discovery Solutions Pvt. Ltd
- Seegene Inc
- Femasys Inc
- Other Prominent Players
HPV Testing and Pap Test Market Segments:
- By Product Type
- HPV test
- Pap test
- Co-test
- By Application
- Cervical cancer
- Vaginal cancer
- By Distribution Channel
- Hospitals and clinics
- Diagnostic centers
- Others
- HPV Testing and Pap Test Market Dynamics
- HPV Testing and Pap Test Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Reasons t%li%Purchase this Report
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2. Business Trends
1.3. HPV Testing and Pap Test Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. HPV Testing and Pap Test Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 HPV TESTING AND PAP TEST MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 HPV TESTING AND PAP TEST MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. HPV test
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Pap test
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Co-test
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1. Cervical cancer
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Vaginal cancer
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By Distribution Channel
11.3.3.1. Hospitals and clinics
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Diagnostic centers
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Others
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Application
12.3.3. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Application
13.3.3. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Application
14.3.3. By Distribution Channel
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Application
15.3.3. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Application
16.3.3. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Arbor vita corporation
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Becton, Dickinson & Company
18.3. Qiagen NV
18.4. Diagcor Bioscience Incorporation Ltd.
18.5. Enzo Biochem, Inc.
18.6. F. Hoffmann-La Roche AG
18.7. Hologic, Inc.
18.8. Mylab Discovery Solutions Pvt. Ltd
18.9. Seegene Inc
18.10. Femasys Inc
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. HPV Testing and Pap Test Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. HPV Testing and Pap Test Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 HPV TESTING AND PAP TEST MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 HPV TESTING AND PAP TEST MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. HPV test
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Pap test
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Co-test
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1. Cervical cancer
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Vaginal cancer
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By Distribution Channel
11.3.3.1. Hospitals and clinics
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Diagnostic centers
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Others
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Application
12.3.3. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Application
13.3.3. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Application
14.3.3. By Distribution Channel
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Application
15.3.3. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA HPV TESTING AND PAP TEST MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Application
16.3.3. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Arbor vita corporation
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Becton, Dickinson & Company
18.3. Qiagen NV
18.4. Diagcor Bioscience Incorporation Ltd.
18.5. Enzo Biochem, Inc.
18.6. F. Hoffmann-La Roche AG
18.7. Hologic, Inc.
18.8. Mylab Discovery Solutions Pvt. Ltd
18.9. Seegene Inc
18.10. Femasys Inc
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
